Customized IOLs: stability matters

Article

When it comes to correcting spherical aberration (SA) of the whole eye, customized IOLs could be a possible approach for the future. However, if high stability of corneal asphericity during cataract surgery is required, it may be necessary to make some improvements to this approach.

When it comes to correcting spherical aberration (SA) of the whole eye, customized IOLs could be a possible approach for the future. However, if high stability of corneal asphericity during cataract surgery is required, it may be necessary to make some improvements to this approach, according to Jochen Wahl from the University of Mainz, Germany.

Customized intraocular lenses (IOLs) require corneal asphericity to remain stable before, during and after cataract surgery and IOL calculations are based on assumptions which look for the postoperative dense position of the base preoperative data. However, this preoperative data may change during surgery, particularly corneal radii and asphericity. With this is in mind, Dr Wahl and Paul-Rolf Preussner set out to investigate how the corneal surface is influenced by the cataract surgery procedure.

The researchers investigated pre- and postoperative topographies of 50 eyes before and after cataract surgery, and at least two months after the procedure. All eyes were operated on by the same surgeon and all eyes had 3 mm temporal clear-corneal incisions. Best-fitting numerical eccentricity of the optical zone was calculated using the 4 parameter corneal model. “We call this the simple model, because we only need four parameters to describe the cornea: the two vertex radii, the angle of the axis and the asphericity,” Wahl explained.

RMS-errors of spatially resolved refraction and wavefront errors were evaluated in addition by ray-tracing of the whole pseudophakic eye, and implications with respect to best-fitting IOL asphericities were investigated.

The researchers found that the asphericity pre- and postoperatively is highly correlated with the numerical eccentricity, being slightly smaller postoperatively than preoperatively. “The difference is, however, too negligible to meet the requirements of customized optics, and as a result some improvements seem to be necessary for customized IOLs,” said Dr Wahl. “One solution may be sclero-corneal incisions, although this may be a step back. Alternatively, smaller corneal incisions may be a better option for customizing IOLs,” concluded Dr Wahl.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.